Back to Search Start Over

Angiotensin II analogues with N-terminal lactam bridge cyclization: an overview on AT 1 receptor activation and tachyphylaxis.

Authors :
Alves FL
Oliveira VX Jr
Miranda A
Source :
Chemical biology & drug design [Chem Biol Drug Des] 2016 Nov; Vol. 88 (5), pp. 677-682. Date of Electronic Publication: 2016 Jun 24.
Publication Year :
2016

Abstract

Angiotensin II (AngII) is the final active product of the renin enzymatic cascade, which is responsible for sustaining blood pressure. To investigate the effect of N-terminal cyclization on AT <subscript>1</subscript> activation and tachyphylaxis, we designed conformationally constrained analogues with an i-(i + 1) lactam bridge. All analogues presented the same binding coefficient and tachyphylactic index, but some of them such as Cyclo (0-1a) [Glu <superscript>0</superscript> , endo-(Lys <superscript>1a</superscript> )]-AngII and Cyclo (0-1a) [Asp <superscript>0</superscript> , endo-(Orn <superscript>1a</superscript> )]-AngII showed higher potency. The same tachyphylactic index presented by AngII and cyclic analogues was surprising. We expected a variation after the modification of AngII N-terminal region.<br /> (© 2016 John Wiley & Sons A/S.)

Details

Language :
English
ISSN :
1747-0285
Volume :
88
Issue :
5
Database :
MEDLINE
Journal :
Chemical biology & drug design
Publication Type :
Academic Journal
Accession number :
27230954
Full Text :
https://doi.org/10.1111/cbdd.12795